2023-10-25T06:39:01-05:00 2022-12-31 BDO USA 8401 GREENSBORO DRIVE 800 MCLEAN VA 22102 990 2022-01-01 311621592 INTERNATIONAL VACCINE INSTITUTE % SEUNGHWA CHEON INTE 8228722803 snu research park 1 gwanak-ro seoul KS 151-742 FRANCOIS BELIN DEP DIR GENERAL, COO 7038930600 2023-09-11 true FRANCOIS BELIN 999009999 Jacob Cook P01240455 7038930600 2023-09-11 2 2022 2023-04-26 12:10:37Z JEROME H KIM snu research park 1 gwanak-ro seoul KS 151-742 76157886 false X www.ivi.int X 1997 TO DISCOVER, DEVELOP AND DELIVER SAFE, EFFECTIVE AND AFFORDABLE VACCINES FOR GLOBAL PUBLIC HEALTH. ITS VISION IS DEVELOPING COUNTRIES FREE OF SUFFERING FROM INFECTIOUS DISEASE. 19 18 223 20 0 0 52941661 77015644 0 0 56420 486502 -964406 -1344260 52033675 76157886 23886182 28444033 0 0 14912622 16444472 0 0 32534 11690949 17397711 50489753 62286216 1543922 13871670 71611847 86735648 4860409 6112540 66751438 80623108 X SEE SCHEDULE O false false 17432867 12209979 0 THE PURPOSE OF GBP510 PHASE III CLINICAL TRIAL IS TO DEMONSTRATE THAT THE IMMUNE RESPONSE INDUCED BY 2 DOSES OF GBP510 AT 4-WEEK INTERVAL IN SERONEGATIVE ADULTS AGED 18 YEARS AND OLDER IS SUPERIOR /NON-INFERIOR TO THE IMMUNE RESPONSE INDUCED BY 2 DOSES OF CHADOX1-S (ASTRAZENECA). IN JANUARY 2022, ALMOST 3500 PARTICIPANTS WERE ENROLLED AT THE 22 STUDY SITES ACROSS 5 COUNTRIES, THAILAND, PHILIPPINES, VIETNAM, NEW ZEALAND AND UKRAINE. THROUGHOUT THE YEAR 2022, 8 PARTICIPANT VISITS WERE COMPLETED INCLUDING 6 BLOOD COLLECTIONS FOR DATA ANALYSIS. FROM Q2 2022, STAGE 2 FOLLOW UP STUDY (IMMUNE RESPONSE OF THIRD DOSE OF GBP510) AT 2 SITES IN THAILAND, STARTED IN PARALLEL WITH THE INITIAL PHASE III STUDY. IN Q3 2022, GBP510, BRAND NAMED SKYCOVIONE HAS BEEN AUTHORIZED BY THE KOREAN MINISTRY OF FOOD AND DRUG SAFETY (KMFDS). 3356282 2299952 0 IN THE FIRST HALF OF 2022, THE GCCDP TEAM COMPLETED QUALITY AUDITS FOR THE STUDY SITES IN COSTA RICA AND PANAMA, AND TWO QUALITY CONTROL VISITS WERE PERFORMED BY IVI STUDY TEAM. IN JUNE, THE SECOND DATA AND SAFETY MONITORING BOARD MEETING WAS HELD AND CONCLUDED WITH A "GO" SAFETY DECISION TO INITIATE THE PHASE III COMPONENT OF THE STUDY. FOLLOW-UP MONITORING OF TRIAL PARTICIPANTS IN PHASE II (850 PPL) CONTINUED FOR 12 MONTHS AND COMPLETED BY NOVEMBER. NO SERIOUS UNEXPECTED ADVERSE REACTIONS HAVE BEEN OBSERVED. THE BRITISH NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL, GCCDP'S PARTNER LABORATORY FOR THE NON-HUMAN PRIMATE (NHP) STUDY, COMPLETED THE ACTIVE IMMUNIZATION STUDY AND THE FINAL REPORT IS NOW AVAILABLE. STUDY DATA DEMONSTRATED POTENT PROTECTION WITH BHARAT BIOTECH'S BBV87 CHIKUNGUNYA VACCINE BY BOTH THE IMPACT ON VIRUS REPLICATION AND HOST RESPONSE TO INFECTION. THE INTERIM CLINICAL STUDY REPORT WAS FINALIZED IN JULY 2022, AND UNBLINDED IMMUNOGENICITY RESULTS ARE NOW AVAILABLE. TOGETHER WITH THE NHP STUDY FINDINGS, THESE RESULTS SUPPORTED THE SELECTION OF THE OPTIMAL DOSE FOR THE PHASE III. MEANWHILE, IVI IS WORKING CLOSELY WITH THE PROJECT'S FUNDER, CEPI, AND THE WHO ON VACCINE VALUE PROFILE DEVELOPMENT FOR CHIKUNGUNYA. 1762090 897872 0 IN 2019, IVI BEGAN SIMPLIFYING OCV THROUGH A REFORMULATION OF THE VACCINE TO LOWER THE COST OF PRODUCTION BY 20% WHILE INCREASING PRODUCTION CAPACITY OF EUVICHOL BY 35%. IN OCTOBER 2022, IVI COMPLETED THE CLINICAL TRIAL COMPARING THE LOWER-COST FORMULATION (EUVICHOL-S) TO SHANCHOL. A FINAL STUDY REPORT IS FORTHCOMING IN EARLY 2023. 27807685 13036230 0 ALL OTHER PROGRAMS 27807685 13036230 0 50358924 true true false false false false false false false false true false false false true false true false false true true true false false true false false true false true false false false true false false false false false false false false false false false false false true 0 0 223 true false true KS false false false false false false false false false false X 19 18 false false false false false true false true true false false false true true true true true true true false X SEUNGHWA CHEON 8228811167 snu research park 1 gwanak-ro seoul KS 151-742 JEROME KIM DIRECTOR GENERAL 40.0 0.0 X X 723004 0 113810 FRANCOIS BELIN CHIEF OPERATING OFFICER 40.0 0.0 X 446807 0 2382 JOHN D CLEMENS SENIOR SCIENTIFIC ADVISOR 40.0 0.0 X 282950 0 71229 ANH WARTEL DEPUTY DIR. GEN, CLINICAL 40.0 0.0 X 295955 0 3554 JULIA LYNCH PROGRAM DIRECTOR, CHOLERA 40.0 0.0 X 255965 0 24806 FLORIAN MARKS DEPUTY DIR. GEN, EPIDEMIOLOGY 40.0 0.0 X 277945 0 2694 TOBIN GUARNACCI GLOBAL HEAD OF QUALITY MGMT 40.0 0.0 X 239272 0 15657 SUSHANT SAHASTRABUDDHE ASSOCIATE DIRECTOR GENERAL 40.0 0.0 X 249563 0 3105 GEORGE BICKERSTAFF CHAIRMAN / BOARD OF TRUSTEE 1.0 0.0 X X 1500 0 0 HANNAH NOHYNEK VICE-CHAIR / BOARD OF TRUSTEE 1.0 0.0 X X 1500 0 0 MALCOLM SWEENEY TREASURER / BOARD OF TRUSTEE 1.0 0.0 X X 1500 0 0 ZIAD AHMED A MEMISH DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 1500 0 0 JEAN-MARIE OKWO-BELE DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 1500 0 0 GORDON DOUGAN DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 750 0 0 ANTHONY FORD-HUTCHINSON DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 750 0 0 CHRIS VARMA DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 500 0 0 RAJIV BAHL DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 RALF CLEMENS DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 JOO-YOEN KANG DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 TAKESHI KASAI DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 OUTI KUIVASNIEMI DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 LEON MUTESA DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 MELANIE SAVILLE DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 KIM SUNG SOON DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 CATHARINA MAIJGREN STEFFENSSON DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 XIMENA GARZON VILLALBA DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 DONG JUN LEE DIRECTOR / BOARD OF TRUSTEE 1.0 0.0 X 0 0 0 2780961 0 237237 32 false true false 0 165698 10377980 66471966 77015644 0 486502 486502 0 0 0 0 0 0 0 165698 0 0 0 0 0 0 0 0 0 FOREIGN EXCHANGE LOSS 900099 -1613729 -1613729 RENTAL FOR RESEARCH COLLABORATION 900099 56171 56171 RENTAL FOR ANIMAL ROOM 900099 34799 34799 178499 178499 -1344260 76157886 -857758 824746 824746 0 27619287 27619287 0 6623484 4177196 2446288 0 0 8052221 6051543 2000678 0 1035100 756726 278374 0 526352 307663 218689 0 207315 135996 71319 0 0 417504 80926 336578 0 57647 3748 53899 0 0 0 0 3219977 2113337 1106640 0 0 2289420 2134980 154145 295 842788 481048 355742 5998 0 1827484 65732 1761752 0 2231737 1908474 322886 377 0 752525 661568 65581 25376 0 0 1447858 369859 1077999 0 102809 72074 30735 0 LAB SUPPLIES 2544893 2438336 106557 0 REPAIRS AND MAINTENANCE 57582 3673 53909 0 TRAINING 52353 5131 47222 0 OTHER EXPENSES 1553134 146881 1405765 488 62286216 50358924 11894758 32534 0 0 40615312 54790470 0 0 11785047 11534313 35715 48880 0 0 0 0 0 0 349565 463818 14960026 8318871 5384642 6641155 0 0 0 0 0 0 13018680 12659544 422886 597468 71611847 86735648 4800778 6060979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 59631 51561 4860409 6112540 X 38082384 41002574 28669054 39620534 66751438 80623108 71611847 86735648 13871670 X false true X true false X 29608736 30794801 51411216 52941661 77015644 241772058 0 0 29608736 30794801 51411216 52941661 77015644 241772058 102007025 139765033 185544 380381 126251 56420 486502 1235098 0 0 0 0 0 0 473063 143408 2347736 0 0 2964207 245971363 69 0.56822 0.59471 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 481439 218026 263413 14435223 8058204 6377019 43364 42641 723 6641155 0 SECURITY DEPOSIT 51561 51561 79267426 79267426 -3109540 -3109540 76157886 65395756 3109540 3109540 62286216 62286216 SCHEDULE D, PART XI, LINE 4B: FOREIGN EXCHANGE LOSS $-3,109,540 SCHEDULE D, PART XII, LINE 2D: FOREIGN EXCHANGE LOSS $3,109,540 true East Asia and the Pacific 7 46 Program Services Program Services 16887911 South Asia 3 19 Program Services Program Services 5788451 Sub-Saharan Africa 8 16 Program Services Program Services 2051409 Central America and the Caribbean 4 5 Program Services Program Services 1773528 Europe (Including Iceland and Greenland) 4 9 Program Services Program Services 750069 North America 1 1 Program Services Program Services 200525 South America 1 4 Program Services Program Services 167394 28 100 28 100 27619287 27619287 East Asia and the Pacific Program Service 12007803 Wire Central America and the Caribbean Program Service 1610652 Wire South Asia Program Service 1396975 Wire East Asia and the Pacific Program Service 1208503 Wire South Asia Program Service 767664 Wire South Asia Program Service 725131 Wire East Asia and the Pacific Program Service 669780 Wire South Asia Program Service 578687 Wire East Asia and the Pacific Program Service 468351 Wire South Asia Program Service 420665 Wire South Asia Program Service 392802 Wire South Asia Program Service 342535 Wire Sub-Saharan Africa Program Service 319279 Wire East Asia and the Pacific Program Service 300936 Wire Sub-Saharan Africa Program Service 297320 Wire North America Program Service 291514 Wire Europe (Including Iceland and Greenland) Program Service 277802 Wire Sub-Saharan Africa Program Service 270000 Wire Sub-Saharan Africa Program Service 251159 Wire East Asia and the Pacific Program Service 248581 Wire Europe (Including Iceland and Greenland) Program Service 239851 Wire South Asia Program Service 206093 Wire North America Program Service 200525 Wire Sub-Saharan Africa Program Service 200094 Wire East Asia and the Pacific Program Service 200000 Wire South Asia Program Service 197749 Wire Sub-Saharan Africa Program Service 175985 Wire North America Program Service 163993 Wire South Asia Program Service 155162 Wire South Asia Program Service 154515 Wire South Asia Program Service 148160 Wire North America Program Service 143231 Wire Sub-Saharan Africa Program Service 138490 Wire South Asia Program Service 133970 Wire East Asia and the Pacific Program Service 117963 Wire East Asia and the Pacific Program Service 110717 Wire Sub-Saharan Africa Program Service 101832 Wire East Asia and the Pacific Program Service 100000 Wire East Asia and the Pacific Program Service 98941 Wire East Asia and the Pacific Program Service 95521 Wire East Asia and the Pacific Program Service 94196 Wire East Asia and the Pacific Program Service 93960 Wire Central America and the Caribbean Program Service 89071 Wire South America Program Service 82274 Wire North America Program Service 80000 Wire East Asia and the Pacific Program Service 78482 Wire East Asia and the Pacific Program Service 78216 Wire Sub-Saharan Africa Program Service 75705 Wire East Asia and the Pacific Program Service 75359 Wire East Asia and the Pacific Program Service 75000 Wire Sub-Saharan Africa Program Service 71804 Wire East Asia and the Pacific Program Service 69556 Wire East Asia and the Pacific Program Service 68033 Wire Central America and the Caribbean Program Service 67805 Wire East Asia and the Pacific Program Service 61911 Wire Sub-Saharan Africa Program Service 61180 Wire South Asia Program Service 60855 Wire East Asia and the Pacific Program Service 60423 Wire North America Program Service 56928 Wire East Asia and the Pacific Program Service 56769 Wire East Asia and the Pacific Program Service 55227 Wire Europe (Including Iceland and Greenland) Program Service 54943 Wire Sub-Saharan Africa Program Service 53156 Wire East Asia and the Pacific Program Service 50733 Wire Europe (Including Iceland and Greenland) Program Service 50000 Wire South America Program Service 48796 Wire East Asia and the Pacific Program Service 46336 Wire Europe (Including Iceland and Greenland) Program Service 46292 Wire Europe (Including Iceland and Greenland) Program Service 45116 Wire South Asia Program Service 43634 Wire East Asia and the Pacific Program Service 40000 Wire East Asia and the Pacific Program Service 38441 Wire North America Program Service 36094 Wire South America Program Service 34554 Wire South Asia Program Service 29702 Wire East Asia and the Pacific Program Service 28192 Wire Europe (Including Iceland and Greenland) Program Service 27768 Wire East Asia and the Pacific Program Service 24544 Wire East Asia and the Pacific Program Service 22872 Wire South Asia Program Service 22152 Wire North America Program Service 21514 Wire East Asia and the Pacific Program Service 21246 Wire East Asia and the Pacific Program Service 21067 Wire East Asia and the Pacific Program Service 20173 Wire East Asia and the Pacific Program Service 20150 Wire North America Program Service 20000 Wire Sub-Saharan Africa Program Service 18311 Wire East Asia and the Pacific Program Service 17000 Wire East Asia and the Pacific Program Service 15157 Wire South Asia Program Service 12000 Wire North America Program Service 11200 Wire Sub-Saharan Africa Program Service 10911 Wire East Asia and the Pacific Program Service 9013 Wire Europe (Including Iceland and Greenland) Program Service 8297 Wire East Asia and the Pacific Program Service 7168 Wire Central America and the Caribbean Program Service 6000 Wire East Asia and the Pacific Program Service 5502 Wire Sub-Saharan Africa Program Service 5103 Wire 67 31 false false false false false false SCHEDULE F, PART I, LINE 2: THE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-TO-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES-DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS-MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT. SPECIAL EVENT 165698 165698 0 0 0 0 0 0 0 165698 165698 0 0 0 0 0 0 0 0 true Public Health Surveillance Group LLC 300 Carnegie Center Princeton NJ 08540 311621592 291514 Program Service Innovations for Global Health 258 N MainSt Doylestown PA 18901 163993 Program Service Brigham and Women's Hospital 15 Francis St Boston MA 02115 550916227 501(c)(3) 143231 Program Service University of Maryland College Park College Park MD 20742 526002033 Maryland State 80000 Program Service President and Fellows of Harvard College Harvard University Massachusetts Ha Cambridge MA 02138 042103580 501(c)(3) 56928 Program Service HJF Medical Research International Inc 6720A Rockledge Drive Bethesda Mar Bethesda MD 20817 522322791 501(c)(3) 36094 Program Service Massachusetts General Hospital 55 Fruit Street Boston Boston MA 02114 041564655 501(c)(3) 21514 Program Service University of Washington Northeast Seattle Seattle WA 9819 Seattle WA 98195 916001537 Washington ST 20000 Program Service Mediana LLC 7063 PR 187 Suite 806 Carolina PR Carolina PR 00979 11200 Program Service 6 3 SCHEDULE I, PART I, LINE 2: THE IVI IS LOCATED IN SEOUL, KOREA WHERE ALL THE GRANT FUNDS ARE MANAGED AND EXECUTED. THE IVI HAS IN PLACE A VERY DETAILED AND RIGOROUS SYSTEM OF FINANCIAL MONITORING. THIS SYSTEM, WHICH IS EVALUATED BY INTERNAL FINANCE PERSONNEL THROUGHOUT THE YEAR AND AUDITED EXTERNALLY EVERY YEAR, IS USED IN CONJUNCTION WITH CAREFUL PROJECT DEVELOPMENT AND IMPLEMENTATION TO ENSURE ACCOUNTABILITY AND BUDGETARY MANAGEMENT RESPONSIBILITY. FOR SUBGRANTS, THE IVI HAS A BROAD OVERALL SYSTEM OF REVIEWING AND TRACKING THE USE OF GRANTS, AND MORE SPECIFIC DAY-TO-DAY REVIEW PROCESSES, WHICH INCLUDE THE FOLLOWING: -REVIEWS OF FINANCIAL AND NARRATIVE REPORTS, AUDIT REPORTS, CORRESPONDENCE AND OTHER DOCUMENTATION PROVIDED BY THE GRANTEES-DIRECT COMMUNICATION WITH GRANTEES THROUGH TELEPHONE AND EMAIL FOR QUESTIONS AND TO CHECK ON PROGRESS OF THE PROJECT -ON-SITE VISITS TO THE FIELD SITES TO REVIEW ONE OR MORE ASPECTS OF THE PROJECTS -MONITORING THROUGH AN EXTERNAL AUDIT. A CERTAIN NUMBER OF SUB-GRANTEES ARE SELECTED FOR THE AUDIT EACH YEAR, WHICH IS DONE TO ENSURE FINANCIAL AND EXPENDITURE COMPLIANCE WITH THE RESEARCH AGREEMENT. X X X X true true X X X X false false false false false false false false false JEROME KIM DIRECTOR GENERAL 397203 0 64003 0 261798 0 113000 0 810 0 836814 0 177003 0 FRANCOIS BELIN CHIEF OPERATING OFFICER 323730 0 0 0 123077 0 0 0 2382 0 449189 0 0 0 JOHN D CLEMENS SENIOR SCIENTIFIC ADVISOR 226570 0 0 0 56380 0 70292 0 937 0 354179 0 49708 0 ANH WARTEL DEPUTY DIR. GEN, CLINICAL 211664 0 0 0 84291 0 0 0 3554 0 299509 0 0 0 JULIA LYNCH PROGRAM DIRECTOR, CHOLERA 217924 0 0 0 38041 0 0 0 24806 0 280771 0 0 0 FLORIAN MARKS DEPUTY DIR. GEN, EPIDEMIOLOGY 220357 0 0 0 57588 0 0 0 2694 0 280639 0 0 0 TOBIN GUARNACCI GLOBAL HEAD OF QUALITY MGMT 162045 0 0 0 77227 0 10000 0 5657 0 254929 0 40000 0 SUSHANT SAHASTRABUDDHE ASSOCIATE DIRECTOR GENERAL 161420 0 0 0 88143 0 0 0 3105 0 252668 0 0 0 SCHEDULE J, PART I, LINE 1A: TRAVEL FOR COMPANION: AFTER 15 MONTHS OF SERVICE, THE INTERNATIONALLY RECRUITED STAFF IS ENTITLED TO HOME LEAVE TRAVEL. THIS ENTITLEMENT IS AN ECONOMY ROUND TRIP BETWEEN DUTY STATION AND HOME BASE FOR STAFF, SPOUSE AND DEPENDENTS UNDER 21. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: IN ORDER TO EQUALIZE THE BENEFITS ACCRUED TO INTERNATIONALLY RECRUITED STAFF, IVI COMPENSATES STAFF WHO ARE OBLIGATED TO PAY TAXES ON IVI DERIVED INCOME TO THEIR HOME COUNTRY. ANY TAX SUBSEQUENTLY LEVIED ON THE AMOUNT OF THE REIMBURSEMENT IS NOT REIMBURSED. IN GENERAL, THIS IS TREATED AS TAXABLE COMPENSATION. HOUSING ALLOWANCE: IVI PROVIDES INTERNATIONALLY RECRUITED STAFF IN KOREA WITH A HOUSING ALLOWANCE UP TO 75% OF A CEILING THAT IS ESTABLISHED AND REVIEWED PERIODICALLY. PERSONAL SERVICES (I.E. DRIVER): IVI PROVIDES THE DIRECTOR GENERAL WITH A DRIVER WHICH IS INCLUDED IN HIS/HER EMPLOYMENT CONTRACT PACKAGE APPROVED BY THE BOARD OF TRUSTEES. Sushant Sahastrabuddhe EMPLOYEE EDUCATION X 16768 11179 false true true Birkneh Tilahun Tadesse EMPLOYEE EDUCATION X 15070 7252 false true true Ruchirkumar Pansuriya EMPLOYEE EDUCATION X 9130 4975 false true true Satyanarayana Bejjani EMPLOYEE EDUCATION X 9581 5562 false true true Tobin Guarnacci EMPLOYEE EDUCATION X 1874 1250 false true true Suneth Agampodi EMPLOYEE EDUCATION X 28711 18663 false true true 48881 FORM 990, PART III, LINE 1: IVI IS THE ONLY INTERNATIONAL ORGANIZATION IN THE WORLD EXCLUSIVELY DEDICATED TO DISCOVERING, DEVELOPING AND DELIVERING VACCINES FOR GLOBAL HEALTH. IVI FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF THE MOST IMPOVERISHED. WE AIM TO MAKE VACCINES AVAILABLE AND ACCESSIBLE FOR VULNERABLE POPULATIONS IN DEVELOPING COUNTRIES. WE LIVE IN AN INCREASINGLY GLOBALIZED WORLD WHERE NEW AND EMERGING INFECTIOUS DISEASES CAN BECOME GLOBAL HEALTH THREATS. IVI ALSO FOCUSES ON VACCINES AGAINST INFECTIOUS DISEASES OF MAJOR GLOBAL HEALTH CONCERN. OUR RESEARCH SPANS THE ENTIRE VACCINE SPECTRUM FROM DISCOVERY AND PRECLINICAL DEVELOPMENT IN OUR SEOUL-BASED LABS TO CLINICAL DEVELOPMENT AT FIELD SITES IN DEVELOPING COUNTRIES TO GENERATING SCIENTIFIC EVIDENCE ON THE NEED FOR VACCINATION IN COUNTRIES WHERE VACCINES ARE MOST NEEDED. OUR HEADQUARTERS IN SEOUL HAVE STATE-OF-THE ART LAB FACILITIES, ANIMAL HOUSE, AND RESEARCH TEAMS THAT INCLUDE CLINICAL IMMUNOLOGY, PROCESS DEVELOPMENT, EPIDEMIOLOGY, CLINICAL & REGULATORY, BIOSTATISTICS & DATA MANAGEMENT, AND POLICY & ECONOMIC RESEARCH. OUTSIDE OF SEOUL, WE HAVE A GLOBAL NETWORK OF FIELD SITES IN MORE THAN 20 COUNTRIES IN ASIA, AFRICA, AND THE AMERICAS. WE MANAGE FIELD SITES IN COLLABORATION WITH REGIONAL AND IN-COUNTRY PARTNERS. WE WORK WITH LOCAL PARTNERS TO IMPLEMENT TRANSLATIONAL AND FIELD RESEARCH PROJECTS, AND WE ALSO PROVIDE TRAINING AND TECHNICAL ASSISTANCE. FORM 990, PART V, LINES 1A AND 2A: IVI'S HEADQUARTERS IS BASED IN SEOUL, KOREA. SINCE THE ORGANIZATION IS NOT UNITED STATES BASED, THE ORGANIZATION HAS ONLY FILED (1) FORM W-2 FOR AN EMPLOYEE RESIDING IN THE UNITED STATES. AS OF DECEMBER 31, 2022, THE ORGANIZATION REPORTS XX EMPLOYEES. FORM 990, PART V, LINE 4: IVI IS A FOREIGN ORGANIZATION. IT IS NOT REQUIRED TO FILE FORM FINCEN 114 (REPORT OF FOREIGN BANK AND FINANCIAL ACCOUNTS). FORM 990, PART VI, LINE 7A: THE DIRECTOR GENERAL OF THE INSTITUTE IS ALSO A VOTING MEMBER OF THE BOARD; THUS, HE/SHE CAN PARTICIPATE IN THE ELECTION OF THE BOARD. FORM 990, PART VI, LINE 11B: THE FINANCE TEAM MAKES A FIRST DRAFT OF FORM 990 AND THE RELATED SCHEDULES. HR PROVIDES SPECIFIC INFORMATION ON COMPENSATION AND OTHER TEAMS PROVIDE FUNDRAISING, GOVERNANCE AND MANAGEMENT INFORMATION. PUBLIC ACCOUNTANT PREPARES THE RETURN ON IVI'S BEHALF AND THIS IS REVIEWED IN TURN BY THE COO AND HEAD OF FINANCE FOR ACCURACY. FORM 990, PART VI, LINE 12C: THE IVI HR PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO ALL DIRECTORS, OFFICERS AND STAFF TO REVIEW AND COMPLETE A DECLARATION OF CONFLICT OF INTEREST ANNUALLY. IN CONNECTION WITH ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST, EACH INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF HIS OR HER SIGNIFICANT FINANCIAL INTERESTS, SIGNIFICANT EQUITY INTERESTS, INTELLECTUAL PROPERTY INTERESTS OR OUTSIDE INTERESTS TO THE CONFLICT COORDINATOR (DIRECTOR GENERAL) WHO MAY CREATE A CONFLICT COMMITTEE COMPOSED OF THREE OTHER MEMBERS OF THE IVI STAFF TO REVIEW CONFLICT OF INTEREST ISSUES THAT MAY ARISE. THE CONFLICT COMMITTEE SHALL BE RESPONSIBLE FOR ENSURING THAT RELEVANT CONFLICTS OF INTEREST, AND THE PROCEDURES TAKEN TO ELIMINATE, REDUCE OR MANAGE THOSE CONFLICTS, ARE DISCLOSED AT OR PRIOR TO ANY BOARD OF TRUSTEES MEETING. THE COMMITTEE SHALL KEEP A RECORD OF ALL ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AND REPORT ANNUALLY THEREON TO THE BOARD OF TRUSTEES. IN CASE OF TRUSTEES, IVI BOARD SECRETARIAT PROVIDES A COPY OF THE CONFLICT OF INTEREST POLICY TO THE MEMBERS WHEN THEY FIRST JOIN, ALL MEMBERS MUST SUBMIT A SIGNED COPY OF THE DISCLOSURE OF ACTUAL AND POTENTIAL CONFLICTS OF INTEREST TO IVI. THE MEMBERS SHOULD REPORT THEIR CHANGES OF STATUS TO THE BOARD SECRETARIAT. FORM 990, PART VI, LINES 15A AND 15B: THE IVI UNDERTAKES A COMPREHENSIVE COMPENSATION STUDY FOR ITS OFFICERS AND KEY EMPLOYEES. A COMPENSATION CONSULTANT CONDUCTS THE STUDY AND LOOKS AT COMPENSATION AMONG COMPARABLE ORGANIZATIONS WITH SIMILAR POSITIONS AND RESPONSIBILITIES IN ORDER TO PROVIDE MARKET DATA TO DETERMINE IVI STAFF MEMBER COMPENSATION. COMPENSATION IS SET BY INDEPENDENT PERSONS, AND CONTEMPORANEOUS DOCUMENTATION OF THE PROCESS IS RETAINED. FORM 990, PART VI, LINE 19: THE IVI'S GOVERNING DOCUMENTS-ESTABLISHMENT AGREEMENT, HEADQUARTERS AGREEMENT, CONSTITUTION AND AMENDMENTS TO THE CONSTITUTION ARE AVAILABLE ON IVI'S WEBSITE. THE SUMMARY OF FINANCIAL REPORT IS INCLUDED IN IVI'S ANNUAL REPORT. THE AUDIT REPORT IS ALSO SHARED ON IVI'S WEBSITE.